Amount | Holding |
---|---|
8.98% | Bristol-Myers Squibb Company |
8.13% | Biogen Inc |
8.08% | Eli Lilly and Co |
7.91% | Novartis AG ADR |
7.91% | Merck & Co Inc |
7.19% | Johnson & Johnson |
6.71% | Pfizer Inc |
6.12% | AstraZeneca PLC ADR |
5.64% | Gilead Sciences Inc |
5.63% | GlaxoSmithKline PLC ADR |
5.56% | Amgen Inc |
5.22% | AbbVie Inc |
5.09% | Sanofi SA ADR |
3.89% | Ionis Pharmaceuticals Inc |
2.08% | Alkermes PLC |
1.45% | CRISPR Therapeutics AG |
1.30% | Arena Pharmaceuticals Inc |
0.82% | Editas Medicine Inc |
0.67% | Intellia Therapeutics Inc |
0.54% | Xenon Pharmaceuticals Inc |
0.25% | Pacific Biosciences of California Inc |
0.18% | Bristol Myers Squibb ([Wts/Rts]) |
0.11% | Merrimack Pharmaceuticals Inc |
0.06% | Warrant on Ligand Pharmaceuticals Inc |
0.02% | Celldex Therapeutics Inc |